Galaxy Surfactants Limited

rs,

bai – 400 051 Scrip Symbol: GALAXYSURF BSE Limited, Listing Department, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Scrip Code: 540935 Sub: Investor presentation on the Unaudited Fin

Rs. 20 Crore

and delays in the availability of critical feedstocks impact Volumes and EBITDA. Adverse impact of Rs. 20 Crores on EBITDA Across the board inflationary scenario combined with Supply Chain volatility (Month on

1%

tical feedstock used for manufacturing performance surfactants. For H1 the volumes have degrown by 1% Specialty Care Products report a decline in Q2FY21 due to supply chain constrains. Overall, for H1

13%

s report a decline in Q2FY21 due to supply chain constrains. Overall, for H1 the same has grown at 13% 4 Volume: Q2FY22 Highlights Performance Surfactants Specialty Care Products Total Volume 41,

0.1%

l Q2FY21 Q1FY22 Q2FY22 Q2FY21 Q1FY22 Q2FY22 Q2FY21 Q1FY22 Q2FY22 India Market grew YoY by 0.1% Africa Middle East Turkey de-grew YoY by 13.3% Rest of the World de-grew YoY by 7.1% While Deman

13.3%

22 Q2FY21 Q1FY22 Q2FY22 India Market grew YoY by 0.1% Africa Middle East Turkey de-grew YoY by 13.3% Rest of the World de-grew YoY by 7.1% While Demand remains robust, inability to service the same

7.1%

grew YoY by 0.1% Africa Middle East Turkey de-grew YoY by 13.3% Rest of the World de-grew YoY by 7.1% While Demand remains robust, inability to service the same due to supply side constraints impinged

13.8%

h g i l h g i H e m u o V l H1FY21 H1FY22 H1FY21 H1FY22 H1FY21 H1FY22 India Market grew by 13.8% Africa Middle East Turkey de-grew by 9.7% Rest of the World grew by 8.8% 6 Q2FY22 & H1FY22 C

9.7%

2 H1FY21 H1FY22 H1FY21 H1FY22 India Market grew by 13.8% Africa Middle East Turkey de-grew by 9.7% Rest of the World grew by 8.8% 6 Q2FY22 & H1FY22 Consolidated Highlights Performance Surfact

8.8%

2 India Market grew by 13.8% Africa Middle East Turkey de-grew by 9.7% Rest of the World grew by 8.8% 6 Q2FY22 & H1FY22 Consolidated Highlights Performance Surfactants Specialty Care Products

8.6%

ncome Total Comprehensive Income EPS As per Ind AS 877.3 5.0 882.3 644.5 47.8 114.2 75.9 8.6% 18.1 57.8 3.7 54.1 12.2 41.9 4.8% 0.5 42.4 11.83 718.7 22.1% 826.4 6.2% 1,703.7 1,325

4.8%

s per Ind AS 877.3 5.0 882.3 644.5 47.8 114.2 75.9 8.6% 18.1 57.8 3.7 54.1 12.2 41.9 4.8% 0.5 42.4 11.83 718.7 22.1% 826.4 6.2% 1,703.7 1,325.8 28.5% 2,784.1 22.0% -39.8% 4.6 723

“No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.”

“Vaijanath Kulkarni Non-Executive Director •Associated with Company since 1995 •Chemical Engineer •Currently, MD of Galaxy Chemicals (Egypt) S.A.E 30 Along with Guidance of Senior Board Members Mr.”

Cash Flow From Operating Activities

4

Communication Address

1

Investor Relations Advisors

1

Communication Address

Rupa Solitaire, Ground Floor, Unit no. 8, 12A and 14 Millennium Business Park, Mahape, Navi Mumbai, 400 710 Ph: +91-22-33063700 Regd. Office: C-49/2, TTC Industrial Area, Pawne, Navi Mumbai-400 703, India CIN: L39877MH1986PLC039877 Ph: +91-22-27616666 Fax : +91-22-27615883/ 27615886 e-mail : galaxy@galaxysurfactants.com Website: www.galaxysurfactants.com Galaxy Surfactants Limited Investor Presentation - November 2021 Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Galaxy Surfactants Limited. (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. Th

Cash Flow From Operating Activities

Profit After Tax Operating Profit before working Capital changes Net cash flows generated from/(used) in Operating Activities (A) Net cash flows generated from/(used) in Investing Activities (B) Net cash flows generated from/(used) in Financing Activities (C) Net Increase/(Decrease) in cash and cash equivalents (A+B+C) Opening cash and cash equivalents Effects of exchange rate changes on the balance of cash and cash equivalents held in foreign currencies Closing cash and cash equivalents Half Year ended Sep’21 Sep’20 118.8 183.5 (25.1) (13.2) 66.0 27.7 81.5 1.2 110.4 138.2 213.8 186.1 (41.0) (131.0) 14.1 47.7 (0.1) 61.7 10 Standalone Profit & Loss Statement Particulars (Rs. In Crores) Q2FY22 Q2FY21 Net Revenue from Operations Other Income Total Revenue Cost of Material Consumed Employee's Benefits Expense Other Expenses EBITDA EBITDA Margin Depreciation EBIT Finance cost PBT Tax expense PAT PAT Margin Other Comprehensive Income Total Comprehensive Income EPS As per Ind AS 624.7 5.7 630

Cash Flow From Operating Activities

Profit After Tax Operating Profit before working Capital changes Net cash flows generated from/(used) in Operating Activities (A) Net cash flows generated from/(used) in Investing Activities (B) Net cash flows generated from/(used) in Financing Activities (C) Net Increase/(Decrease) in cash and cash equivalents (A+B+C) Opening cash and cash equivalents Effects of exchange rate changes on the balance of cash and cash equivalents held in foreign currencies Closing cash and cash equivalents Half Year ended Sep’21 Sep’20 66.8 107.8 18.7 (43.7) 16.6 (8.5) 11.9 0.0 3.4 92.0 149.1 133.8 (43.2) (90.5) 0.1 16.9 0.9 17.9 13 Business Overview 14 Truly Indian MNC… Leading manufacturer of Ingredient for Home & Personal care Industry (HPC) Product applications across Mass, Mass-tige & Prestige range of Customers Preferred supplier to leading Multinational, Regional & Local FMCG Brands Brand Custodian Globally Recognized Integrated Across Full Value Chain of HPC Industry Advanced portfolio of Innovat

Cash Flow From Operating Activities

Profit After Tax Operating Profit before working Capital changes Net cash flows generated from/(used) in Operating Activities (A) Net cash flows generated from/(used) in Investing Activities (B) Net cash flows generated from/(used) in Financing Activities (C) Net Increase/(Decrease) in cash and cash equivalents (A+B+C) Opening cash and cash equivalents Effects of exchange rate changes on the balance of cash and cash equivalents held in foreign currencies Closing cash and cash equivalents Full Year ended Mar’21 Mar’20 302.1 454.2 365.1 230.4 373.0 315.9 (164.7) (150.8) (165.0) (143.8) 35.4 47.7 (1.6) 81.5 21.3 25.0 1.4 47.7 43 Standalone Balance Sheet Particulars (Rs. In Crores) ASSETS Property, Plant and Equipment Right-of-use assets Capital work-in-progress Goodwill Other Intangible Assets Financial Assets (i) Investments (ii) Loans (iii) Other financial assets Deferred Tax Assets (Net) Income Tax Assets (Net) Other Non-current tax assets Total Non-Current Assets Current Assets Invent

Cash Flow From Operating Activities

Profit After Tax Operating Profit before working Capital changes Net cash flows generated from/(used) in Operating Activities (A) Net cash flows generated from/(used) in Investing Activities (B) Net cash flows generated from/(used) in Financing Activities (C) Net Increase/(Decrease) in cash and cash equivalents (A+B+C) Opening cash and cash equivalents Effects of exchange rate changes on the balance of cash and cash equivalents held in foreign currencies Closing cash and cash equivalents Full Year ended Mar’21 Mar’20 177.9 296.5 183.7 182.2 284.0 212.5 (104.5) (37.9) (84.2) (160.7) (5.0) 16.9 0.0 11.9 13.9 3.9 (0.9) 16.9 45 Thank You

Investor Relations Advisors

CIN No: L39877MH1986PLC039877 CIN - U74140MH2010PTC204285 Mr. Paritosh Srivastava Email: Paritosh.Srivastava@galaxysurfactants.com Mr. Rahul Agarwal / Mr. Vijay Goel rahul.agarwal@sgapl.net / vijay.goel@sgapl.net www.galaxysurfactants.com +91 98214 38864 / +91 99201 24357 www.sgapl.net 46